CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)		Total	Additional Paid-in Capital	Accumulated Deficit	Class A Ordinary Shares Subject To Redemotion Common Stock	Class A Ordinary Shares	Class B Ordinary Shares		Class B Ordinary Shares Common Stock
Beginning Balance (in shares) at Jan. 23, 2020									0
Beginning Balance at Jan. 23, 2020		$ 0	$ 0	$ 0					$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(112,317)		(112,317)
Ending Balance (in shares) at Mar. 31, 2020									0
Ending Balance at Mar. 31, 2020		(112,317)	0	(112,317)					$ 0
Beginning Balance (in shares) at Jan. 23, 2020									0
Beginning Balance at Jan. 23, 2020		0	0	0					$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(13,845)				$ 0	$ (13,845)
Ending Balance (in shares) at Sep. 30, 2020	[1]								25,000,000
Ending Balance at Sep. 30, 2020	[1]	11,155	22,500	(13,845)					$ 2,500
Beginning Balance (in shares) at Mar. 31, 2020									0
Beginning Balance at Mar. 31, 2020		(112,317)	0	(112,317)					$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issuance (in shares)									25,000,000
Issuance of Class B ordinary shares to Sponsor		25,000	22,500						$ 2,500
Net income (loss)		98,553		98,553
Ending Balance (in shares) at Jun. 30, 2020									25,000,000
Ending Balance at Jun. 30, 2020		11,236	22,500	(13,764)					$ 2,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(81)		(81)		0	$ (81)
Ending Balance (in shares) at Sep. 30, 2020	[1]								25,000,000
Ending Balance at Sep. 30, 2020	[1]	11,155	22,500	(13,845)					$ 2,500
Beginning Balance (in shares) at Dec. 31, 2020					0		25,000,000	[2]	25,000,000	[1]
Beginning Balance at Dec. 31, 2020	[1]	11,155	22,500	(13,845)					$ 2,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Class A ordinary shares to redemption amount		(84,467,273)	(22,500)	(84,444,773)
Net income (loss)		20,380,504		20,380,504
Ending Balance (in shares) at Mar. 31, 2021									25,000,000
Ending Balance at Mar. 31, 2021		(64,075,614)	0	(64,078,114)					$ 2,500
Beginning Balance (in shares) at Dec. 31, 2020					0		25,000,000	[2]	25,000,000	[1]
Beginning Balance at Dec. 31, 2020	[1]	11,155	22,500	(13,845)					$ 2,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		20,129,873				$ 16,103,898	$ 4,025,975
Ending Balance (in shares) at Sep. 30, 2021						100,000,000	25,000,000		25,000,000
Ending Balance at Sep. 30, 2021		(64,376,366)	0	(64,378,866)					$ 2,500
Beginning Balance (in shares) at Mar. 31, 2021									25,000,000
Beginning Balance at Mar. 31, 2021		(64,075,614)	0	(64,078,114)					$ 2,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Class A ordinary shares to redemption amount		(50,121)	0	(50,121)
Net income (loss)		(14,050,247)		(14,050,247)
Ending Balance (in shares) at Jun. 30, 2021									25,000,000
Ending Balance at Jun. 30, 2021		(78,175,982)	0	(78,178,482)					$ 2,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		13,799,616		13,799,616		$ 11,039,693	$ 2,759,923
Ending Balance (in shares) at Sep. 30, 2021						100,000,000	25,000,000		25,000,000
Ending Balance at Sep. 30, 2021		$ (64,376,366)	$ 0	$ (64,378,866)					$ 2,500

[1] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of September 30, 2020 and December 31, 2020 have been retroactively restated to account for the share recapitalization events as discussed in Note 5.

[2] On February 4, 2021, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Share amounts as of December 31, 2020 have been retroactively restated to account for the share recapitalization events as discussed in Note 5.